May 30, 2018 | Harriet Kozak, Intellus, Rachel Howard, USA, emerging markets
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry.
As part of the keynote speeches, we were honored to hear the perspective of patient advocates and leaders in rare disease. Hearing directly from patients who had lived through unimaginably challenging experiences provided a humbling reminder and refocusing of our common goal as an industry – to ultimately improve patients’ lives.
Find out more:Â https://www.researchpartnership.com/news/2018/05/intellus-round-up-2018/
This content was provided by Inizio
Latest Content from Inizio
All eyes on Spinraza
In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch…
Download our pre-launch checklist
The key to conducting effective rare disease research
Download our third Innovation in #MRX webcast, hosted in partnership with Convosphere, where we discuss how to use social media listening to answer key business questions.Watch here: https://bit.ly/2nM0xvj
Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. As…
Our latest infographic outlines the changes to the clinical trial process, accelerated drug approval, fast track of rare disease products and access opportunities in China’s evolving healthcare environment.Find out more here-…
Research Partnership were delighted to exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with one of this year’s MR Excellence Awards.Find out…
Research Partnership’s client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just…
Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients…
